Promoting the Use of CPAP Therapy Among OSA Patients

Obstructive Sleep Apnea Clinical Trial

Official title:

A Tailored Sleep Behavior Change Support System to Promote the Use of Continuous Positive Airway Pressure Therapy: Theorizing the Solution

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04372329
• Other study ID #: 3726
• Status: Completed
• Phase: N/A
• Start date: July 1, 2020
• Est. completion date: September 30, 2021

Study information

• Verified date: August 2022
• Source: Claremont Graduate University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Obstructive sleep apnea (OSA) is the most common sleep breathing disorder in the U.S. Continuous Positive Airway Pressure (CPAP) therapy is the most effective treatment for OSA. However, up to 50% of patients who accept using CPAP therapy fail to adhere to it. This study will evaluate an information systems (IS)-based solution that sends tailored, motivational, educational messages and tailored feedback messages to promote CPAP usage among noncompliant OSA patients. The primary aim of this study is to determine the efficacy of the proposed IS solution and its effect on fostering the use of CPAP therapy among OSA patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. completion date: September 30, 2021
• Est. primary completion date: September 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of OSA

• Prescribed treatment of CPAP therapy

• Possession of a mobile phone that has multimedia messaging capabilities

• Capacity to consent.

Exclusion Criteria:

• Unable to speak and read English

Related Conditions & MeSH terms

• Obstructive Sleep Apnea
• Sleep Apnea, Obstructive

Intervention

Behavioral:
• CPAP4HealthySleep system
Tailored multimedia messages and tailored feedback messages delivered via web-based system to participants' phones to motivate them to use their CPAP therapy

Locations

Country	Name	City	State
United States	Pomona Valley Hospital Medical Center Adults and Children Sleep Disorders Center	Claremont	California

Sponsors (1)

Lead Sponsor	Collaborator
Sarah Alismail

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in CPAP usage	The average number of hours per week of CPAP usage.	During 19 weeks
Primary	CPAP compliance	Compliance of CPAP use characterized by mask-on time at the prescribed pressure for = 4 hours/day for 70% of monitored nights.	19 weeks